X-ZELL technology suite upgrade underway

X-ZELL technology suite upgrade underway Singapore, October 2018 – Cancer detection specialist, X-ZELL Inc., has announced a new version of the company’s world-unique Cryoimmunostaining™ suite. Whilst keeping details close to his chest, X-ZELL’s Head of Engineering...

More Bangkok hospitals embrace ground-breaking new liquid biopsy

Bangkok hospitals embrace ground-breaking new liquid biopsy Bangkok, October 2018 – Prostate cancer patients in Bangkok now have more access to state-of-the-art cancer detection technology than ever before. After debuting at Bangkok’s Chularat 9 Hospital at the end of...

X-ZELL officially incorporated in Singapore

X-ZELL officially incorporated in Singapore Singapore, October 2018 – X-ZELL Inc., only recently named one of Asia’s 20 most innovative health tech start-ups, is coming to Singapore. According to X-ZELL CEO, Dr Sebastian Bhakdi, the rare cell detection specialist’s...

X-ZELL among 20 most innovative health-tech start-ups in Asia

X-ZELL among Asia's 20 most innovative health-tech start-ups Singapore, September 2018 – Galen Growth, a Singapore-based analytics and advisory firm specialising in cutting-edge healthcare technology, has named X-ZELL Inc. as one of the 20 most innovative health...

X-ZELL technology featured in British urology journal

Ground-breaking X-ZELL research featured in BJU International Oxford, August 2018 – X-ZELL Inc. CEO, Dr Sebastian Bhakdi, has published new research into the utility of tumour-derived Circulating Endothelial Cells (tCEC) for the detection of early-stage prostate...

X-ZELL launches global Cryoimmunostaining™ technology trial

Applications for global Cryoimmunostaining™ technology trial now open Bangkok, July 2018 – After successfully completing a series of clinical trials across Southeast Asia, rare cell detection specialist X-ZELL Inc. is now making the company’s patented...